Baxter International Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • BAX
  • 1d-0.56%
  • 1w-1.89%
  • 1m-3.70%
  • 1y2.55%
ATH
  • ATH Price$93.89
  • ATH Date2020-04-20
  • % since ATH-11.07%
  • % to ATH12.45%
ATL
  • ATL Price$4.14
  • ATL Date1984-12-04
  • % from ATL1,916.18%
  • Last Low Price$83.49
  • Last Low Date2020-06-23
  • % From Last Low0%
IPO
  • IPO Price$0.00
  • % Current ROI USDN/A
  • ATH Price$93.89
  • % ROI ATH 226,720.84%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="BAX"]

Key Data [addtoany]

Current price $83.49
Sector Healthcare
Industry Medical Instruments & Supplies
Today's High/Low $84.67/$83.38
Volume 2,314,371.00
Previous Close $83.96
52 Week High/Low $95.19/$69.1
Market Cap 42,706,604,032.00
P/E Ratio 43.9581
Forward P/E 1 Yr. $25.38
Earnings Per Share(EPS) $3.82
Annualized Dividend $0.0116
$83.49
[addtoany]

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals.
Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients at home under physician supervision.
The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.
It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity